HOME › DRUGS › SERPLULIMAB
ACTIVE SUBSTANCE / INN

SERPLULIMAB

Brand name(s): Hetronifly
EMA LISTED
AUTHORISED
Small Cell Lung Carcinoma
ACTIVE SUBSTANCE
Serplulimab
REGULATORS
EMA
SPONSORS / MAH
Accord Healthcare S.L.U.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
HetroniflyAccord Healthcare S.L.U.Authorised03/02/2025Small Cell Lung Carcinoma

FULL INTELLIGENCE ON SERPLULIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →